MEGZYME Lysozyme is a recombinant bio-fermented enzyme preparation specifically cleaving the β-1,4 glycosidic bonds in bacterial peptidoglycan walls, offering broad-spectrum, gentle biological microbial control.
Safe, non-resistant, and non-disruptive to natural skin commensal flora, it excels in oil-control, blemish-prone skin care, and gentle preservative-boosting systems, providing a pure biotechnology foundation for hypoallergenic formulations.
Enzyme Cleavage Model
Biomimetic targeted enzyme catalytic hydrolysis and high-purity separation.
RAW MATERIAL TECHNICAL & REGULATORY DOSSIER
Comprehensive Technical, Quality Specification, and Regulatory Dossier for R&D Formulators, Procurement, and Product Managers
📊
Biotechnology Mechanism & Scientific Evidence
Authoritative Brochure Technical Diagram · Molecular Model · Transdermal & Efficacy Mechanism
Mechanism DiagramRecombinant active enzyme fermentation plant and GMP standard separation & purification line.
🔬
Formulation R&D Engineer Guide (R&D Technical Dossier)
Formulation Application · Physicochemical Parameters · Stability & Compatibility
| INCI Name (CN) |
probiotic、Glycerin、氯化钠、aqua |
INCI Name (EN) |
Lysozyme, Glycerin, Sodium Chloride, Aqua |
| CAS No. |
9001-63-2 / 56-81-5 / 7647-14-5 / 7732-18-5 |
Recommended Dosage |
0.5% - 2.0% (Recommended 1.0%) |
| Optimal pH Range |
5.5 - 7.5 |
Thermal Processing |
Add below 45°C during the cooling phase |
| Appearance & Odor |
Clear colorless liquid, odorless |
Solubility & Method |
Completely soluble in aqueous solutions |
💡 Compatibility Guidelines & Precautions: Compatible with most mild non-ionic and amphoteric surfactants; avoid strong anionic surfactants
📦
Procurement & Compliance Dossier (Procurement & Compliance)
NMPA Code · MOQ · Sampling Support · Certificate of Analysis
| NMPA Submission Code |
✓ 205471-00075-6889 |
Supply Packaging |
1kg/fluorinated bottle, 5kg/drum, 25kg/drum |
| Minimum Order Quantity (MOQ) |
1 kg (Ready Stock) |
Delivery Lead Time |
Dispatched within 24-48 hours |
| Storage Conditions |
Store refrigerated at 2-8°C, protected from light |
Shelf Life (Shelf Life) |
24 Months |
| R&D Sample Support |
Complimentary 30g trial sample available |
Quality Documentation |
Batch COA, SDS, TDS, Enzymatic Activity Assay Certificate |
💡
Product Planning & Marketing Highlights (Marketing Highlights)
Core Mechanism · Efficacy Claims · Recommended Formats · Scientific Backing
🧬 Core Bio-Tech Barrier & Mechanism of Action:
Selectively cleaves beta-1,4-glycosidic bonds between N-acetylmuramic acid and N-acetylglucosamine in peptidoglycan, inhibiting C. acnes and S. aureus without disrupting beneficial commensal microbiota.
✨ Key Selling Point Keywords:
🏷️ Gentle Oil-Control & Blemish Clarifying🏷️ Balancing Skin Micro-Ecology🏷️ Improving Closed Comedones🏷️ Protecting Natural Sebum Film🏷️ Purifying & Refreshing Soothing
🧴 Recommended Product Formats & Categories:
Acne-prone skin serums, clarifying cleansing foams, anti-dandruff scalp tonics, intimate hygiene gels
📜 Patented Technologies & Scientific Backing:
Patent on Deep-Sea Psychrophilic Enzyme Fermentation & Stabilization
⚖️
Regulatory Compliance & Peer-to-Peer Disclaimer
Regulatory & Professional Compliance Statement:
1. The raw material characteristics and experimental data (including cytological studies, mechanism diagrams, and literature citations) presented on this webpage are intended exclusively for technical discussion and formulation R&D reference by cosmetic brand formulators, R&D engineers, product planners, and academic research institutions. They do not constitute finished consumer cosmetic efficacy claims or commercial warranties.
2. Pursuant to the Regulations on the Supervision and Administration of Cosmetics, Standards for Cosmetic Efficacy Claim Evaluation, and relevant global cosmetic regulatory frameworks, cosmetic brand enterprises utilizing this raw material shall be solely responsible for the safety, stability, and efficacy claims of their finished consumer products, and shall independently complete efficacy evaluations and regulatory filings/registrations with the competent health authorities prior to commercial launch. Conclusions from in-vitro or cellular studies shall not be directly extrapolated as consumer claims.
3. Mellgen Biotech assumes no joint or indirect liability for any claims or regulatory non-compliance arising from improper customer formulation, unauthorized off-label claims, or unverified applications.
